Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B
PaperCitations, authors & open-access status
Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 64 citations, 2016 year and closed oa status.
64
Citations
2016
Year
closed
OA Status